- Home
- ALGS vs AWRE Comparison
ALGS vs AWRE Comparison
Compare ALGS & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- AWRE
- Stock Information
- Founded
- ALGS 2018
- AWRE 1986
- Country
- ALGS United States
- AWRE United States
- Employees
- ALGS N/A
- AWRE N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- AWRE Computer Software: Prepackaged Software
- Sector
- ALGS Health Care
- AWRE Technology
- Exchange
- ALGS Nasdaq
- AWRE Nasdaq
- Market Cap
- ALGS 53.0M
- AWRE 53.6M
- IPO Year
- ALGS 2020
- AWRE 1996
- Fundamental
- Price
- ALGS $9.13
- AWRE $2.33
- Analyst Decision
- ALGS Strong Buy
- AWRE
- Analyst Count
- ALGS 1
- AWRE 0
- Target Price
- ALGS $70.00
- AWRE N/A
- AVG Volume (30 Days)
- ALGS 84.2K
- AWRE 53.2K
- Earning Date
- ALGS 08-05-2025
- AWRE 07-30-2025
- Dividend Yield
- ALGS N/A
- AWRE N/A
- EPS Growth
- ALGS N/A
- AWRE N/A
- EPS
- ALGS N/A
- AWRE N/A
- Revenue
- ALGS $3,270,000.00
- AWRE $16,576,000.00
- Revenue This Year
- ALGS N/A
- AWRE N/A
- Revenue Next Year
- ALGS $51.55
- AWRE N/A
- P/E Ratio
- ALGS N/A
- AWRE N/A
- Revenue Growth
- ALGS N/A
- AWRE N/A
- 52 Week Low
- ALGS $3.76
- AWRE $1.35
- 52 Week High
- ALGS $46.80
- AWRE $2.97
- Technical
- Relative Strength Index (RSI)
- ALGS 59.79
- AWRE 61.58
- Support Level
- ALGS $8.18
- AWRE $2.24
- Resistance Level
- ALGS $9.44
- AWRE $2.65
- Average True Range (ATR)
- ALGS 0.71
- AWRE 0.17
- MACD
- ALGS 0.01
- AWRE 0.02
- Stochastic Oscillator
- ALGS 65.95
- AWRE 60.49
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About AWRE Aware Inc.
Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.